Clinical Trials Browser

Phase 1/2 × Topotecan × Tumor-Agnostic × Clear all

NCT02813135 2026-01-16

ESMART

Phase 1/2 Recruiting

Neoplasms

NCT00382733 2013-07-22

Oral Topotecan to Treat Recurrent or Persistent Solid Tumors

Phase 1/2 Completed

26 enrolled 8 charts

Neoplasms